Resistance to Activated Protein C and Legg-Perthes Disease
- 1 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health
- Vol. 338 (338) , 139-152
- https://doi.org/10.1097/00003086-199705000-00021
Abstract
Thrombophilia may cause thrombotic venous occlusion in the femoral head, with venous hypertension and hypoxic bone death, leading to Legg-Perthes disease. Resistance to activated protein C, the most common thrombophilic trait, was measured in 64 children with Legg-Perthes disease. Genomic deoxyribonucleic acid was studied to delineate the CGA→CAA substitution at position 1691 of the Factor V Leiden gene responsible for resistance to activated protein C. The activated protein C ratio was calculated by dividing clotting time obtained with activated protein C-calcium chloride by clotting time obtained with calcium chloride alone. Resistance to activated protein C, with a low activated protein C ratio (less than 2.19, the 5th percentile for 160 normal pediatric controls) was the most common coagulation defect, found in 23 of 64 children with Legg-Perthes disease versus 7 of 160 pediatric controls. Eight of 64 children with Legg-Perthes disease had a low activated protein C ratio and the mutant Factor V gene (7 heterozygotes, 1 homozygote) versus 1 of 101 normal pediatric controls. Two or 3 generation vertical and horizontal transmission of heterozygosity for the mutant Factor V gene was found in 4 of the 8 kindreds. Of 64 children with Legg-Perthes disease, only 14 (22%) had entirely normal coagulation measures. Resistance to activated protein C appears to be a pathogenetic cause of Legg-Perthes disease.Keywords
This publication has 22 references indexed in Scilit:
- Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jawsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1996
- Association of Antithrombotic Factor Deficiencies and Hypofibrinolysis with Legg-Perthes Disease*Journal of Bone and Joint Surgery, 1996
- Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with stanozololAmerican Journal of Hematology, 1995
- Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor VNew England Journal of Medicine, 1994
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Protein C and S Deficiency, Thrombophilia, and Hypofibrinolysis: Pathophysiologic Causes of Legg-Perthes DiseasePediatric Research, 1994
- Hypofibrinolysis: A common, major cause of osteonecrosisAmerican Journal of Hematology, 1994
- Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and d-dimerMetabolism, 1993
- Non-Traumatic Necrosis of the Femoral HeadJournal of Bone and Joint Surgery, 1970